We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+11.4%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.6B
AUM Growth
+$2.24B
Cap. Flow
-$670M
Cap. Flow %
-1.57%
Top 10 Hldgs %
15.36%
Holding
2,428
New
206
Increased
703
Reduced
1,198
Closed
187

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$204M
2
JPM icon
JPMorgan Chase
JPM
+$72.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$67.5M
4
EVRG icon
Evergy
EVRG
+$66.6M
5
NVDA icon
NVIDIA
NVDA
+$58.5M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$370M
2
UPS icon
United Parcel Service
UPS
+$364M
3
D icon
Dominion Energy
D
+$172M
4
MRNA icon
Moderna
MRNA
+$125M
5
TDOC icon
Teladoc Health
TDOC
+$114M

Sector Composition

Rank Sector Weight
1 Healthcare 22.43%
2 Technology 20.08%
3 Consumer Discretionary 10.99%
4 Financials 9.65%
5 Industrials 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDW icon
1876
CDW
CDW
$18.9B
$23K ﹤0.01%
196
-133
-40% -$15.2K
UNIT
1877
Uniti Group
UNIT
$2.42B
$23K ﹤0.01%
2,137
-58
-3% -$562
VTR icon
1878
Ventas
VTR
$45.6B
$23K ﹤0.01%
541
-108
-17% -$4.32K
MGNI icon
1879
Magnite
MGNI
$3.44B
$22K ﹤0.01%
+3,184
New +$21.3K
ORGO icon
1880
Organogenesis Holdings
ORGO
$183M
$22K ﹤0.01%
5,758
-163
-3% -$644
PIPR icon
1881
Piper Sandler
PIPR
$5.18B
$22K ﹤0.01%
+1,224
New +$20.9K
PLX icon
1882
Protalix BioTherapeutics
PLX
$214M
$22K ﹤0.01%
5,761
UFPI icon
1883
UFP Industries
UFPI
$4.53B
$22K ﹤0.01%
393
-12
-3% -$677
BXC icon
1884
BlueLinx
BXC
$606M
$21K ﹤0.01%
986
-106
-10% -$1.71K
CTSO icon
1885
Cytosorbents Corp
CTSO
$18.2M
$21K ﹤0.01%
131
+55
+72% +$9.93K
MYRG icon
1886
MYR Group
MYRG
$4.3B
$21K ﹤0.01%
572
-13
-2% -$461
OFG icon
1887
OFG Bancorp
OFG
$2.23B
$21K ﹤0.01%
1,661
-27,553
-94% -$361K
UFPT icon
1888
UFP Technologies
UFPT
$2.18B
$21K ﹤0.01%
509
AFI
1889
DELISTED
Armstrong Flooring, Inc.
AFI
$21K ﹤0.01%
6,095
-472
-7% -$1.65K
BPFH
1890
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$21K ﹤0.01%
3,863
BANR icon
1891
Banner Corp
BANR
$2.63B
$20K ﹤0.01%
634
+81
+15% +$2.85K
BRKL
1892
DELISTED
Brookline Bancorp
BRKL
$20K ﹤0.01%
2,348
-41,280
-95% -$392K
CDE icon
1893
Coeur Mining
CDE
$20B
$20K ﹤0.01%
2,658
-2,145
-45% -$16.1K
CHCO icon
1894
City Holding Co
CHCO
$2.03B
$20K ﹤0.01%
343
-11
-3% -$688
CNS icon
1895
Cohen & Steers
CNS
$3.7B
$20K ﹤0.01%
361
+88
+32% +$5.43K
RLGT icon
1896
Radiant Logistics
RLGT
$432M
$20K ﹤0.01%
3,927
-341
-8% -$1.64K
BOOM icon
1897
DMC Global
BOOM
$131M
$19K ﹤0.01%
583
-102,061
-99% -$3.22M
GORO icon
1898
Goldgroup Mining
GORO
$490M
$19K ﹤0.01%
1,385
-773
-36% -$12.6K
HUBG icon
1899
HUB Group
HUBG
$2.03B
$19K ﹤0.01%
762
-22
-3% -$569
MSTR icon
1900
Strategy Inc
MSTR
$49.9B
$19K ﹤0.01%
1,210
-40
-3% -$541

Similar funds

Federated Hermes's Q3 2020 Portfolio in Review

As of Q3 2020, Federated Hermes held 2,428 positions worth $42.6B, up 5.5% from $40.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q3 2020 filing shows 206 new, 703 increased, 1,198 reduced and 187 closed positions. Its largest new stake was Snowflake: 234,132 shares worth $58.8M. The largest sale was Alibaba, an estimated $370M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Federated Hermes's largest Q3 2020 buy was Snowflake: 234,132 shares worth $58.8M.
  • Federated Hermes added most to Gilead Sciences in Q3 2020, an estimated $204M increase.
  • Federated Hermes's biggest Q3 2020 reduction was Alibaba, cutting an estimated $370M.
  • Federated Hermes fully exited BP in Q3 2020, selling an estimated $65.1M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.6B portfolio in Q3 2020.
  • Federated Hermes opened 206 new positions and closed 187 in Q3 2020.
  • Federated Hermes's portfolio value rose 5.5% quarter-over-quarter to $42.6B.

Based on Federated Hermes's 13F filing for Q3 2020, filed 12 Nov 2020.